• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC. FUSION SARS COV-2/FLU/RSV; PANTHER FUSION SARS COV-2/FLU A/B/RSV ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC. FUSION SARS COV-2/FLU/RSV; PANTHER FUSION SARS COV-2/FLU A/B/RSV ASSAY Back to Search Results
Catalog Number PRD-07400
Medical Device Problem Code Erratic Results (4059)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/22/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Hologic technical support (ts) and product application support (pas) reviewed logs from 08/19/24 to 08/22/24 and confirmed that on wl 003394-20240819-14, 3 out of 38 samples produced positive flu b/sars-cov-2 results; from wl 003394-20240820-64, 6 out of 53 samples produced positive flu b/sars-cov-2 results; from on wl-003394-20240821-78, 6 out of 24 samples produced positive flu b/sars-cov-2 results.Ts reviewed the positive samples in question from the initial run and noted that all positive results for flu b and sars-cov-2 had >2000 rfu range with the threshold being 1000.Based on the curves, ts observed that the results appear to be false.The customer noted that this issue is recent, as they have been running the sars/flu a/b/rsv since the beginning of the year.Hologic completed a risk assessment and concluded that the risk of customer questioning results and/or the risk of false flu b positive result when a patient sample is sars-cov-2 positive is broadly acceptable.Hologic informed all quest sites about ctb-01273 that there is a potential erroneous influenza b virus (flu b) positive results when testing with the panther fusion sars-cov-2/flu a/b/rsv assay on the panther fusion system.Hologic implemented an update to the crosstalk correction algorithm of the panther fusion sars-cov-2/flu a/b/rsv assay software.Hologic confirmed that the software 7.2.7 version for panther fusion systems sn 2090003394 (08/28/24) and sn 2090000527 (08/29/24)were upgraded.H3 other text : other.
 
Event or Problem Description
On 08/22/2024, quest diagnostics customer site reported to hologic that they had false positive flu-b results across multiple worklists (wl) while using the sars/flu a/b/rsv assay (cartridge ln 887424) (ml 890419) on panther fusion instrument (sn (b)(6).Customer reported multiple flu b and sars-cov-2 dual positive results in the last few runs.Customer retested the associated sars-cov-2 and flu b dual positive samples on their other panther fusion instrument (b)(6), which resulted in sars-cov-2 positive and flu b negative results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FUSION SARS COV-2/FLU/RSV
Common Device Name
PANTHER FUSION SARS COV-2/FLU A/B/RSV ASSAY
Manufacturer (Section D)
HOLOGIC, INC.
10210 genetic center drive
san diego CA 92121
Manufacturer (Section G)
HOLOGIC, INC.
10210 genetic center drive
san diego CA 92121
Manufacturer Contact
maria osorio
10210 genetic center drive
san diego, CA 92121
8584108109
MDR Report Key20263844
Report Number2024800-2024-00014
Device Sequence Number11354345
Product Code QOF
UDI-Device Identifier15420045515352
UDI-Public15420045515352
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Catalogue NumberPRD-07400
Device Lot Number890419
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/22/2024
Initial Report FDA Received Date09/19/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device A
Patient Sequence Number1
Patient SexUnknown
-
-